Art

J-GLOBAL ID：201802282897936169   Reference number：18A1012430

Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy

同時化学放射線療法で治療された限局性ナチュラルキラー/T細胞リンパ腫患者における早期疾患進行

Author (23)： Yamaguchi Motoko (Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan) ,  Suzuki Ritsuro (Department of Oncology/Hematology, Shimane University Hospital, Izumo, Japan) ,  Kim Seok Jin (Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) ,  Ko Young Hyeh (Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) ,  Oguchi Masahiko (Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Asano Naoko (Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan) ,  Miyazaki Kana (Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan) ,  Terui Yasuhiko (Department of Hematology and Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan) ,  Kubota Nobuko (Division of Hematology, Saitama Cancer Center, Ina, Japan) ,  Maeda Takeshi (Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan) ,  Kobayashi Yukio (Hematology Division, National Cancer Center Hospital, Tokyo, Japan) ,  Amaki Jun (Division of Hematology & Oncology, Tokai University School of Medicine, Isehara, Japan) ,  Soejima Toshinori (Department of Radiation Oncology, Hyogo Cancer Center, Akashi, Japan) ,  Saito Bungo (Division of Hematology, Showa University School of Medicine, Tokyo, Japan) ,  Shimoda Emiko (Department of Radiation Oncology, Nara Medical University, Kashihara, Japan) ,  Fukuhara Noriko (Department of Hematology & Rheumatology, Tohoku University Hospital, Sendai, Japan) ,  Tsukamoto Norifumi (Oncology Center, Gunma University Hospital, Maebashi, Japan) ,  Shimada Kazuyuki (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Choi Ilseung (Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan) ,  Utsumi Takahiko (Department of Hematology, Shiga Medical Center for Adults, Moriyama, Japan) ,  Ejima Yasuo (Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan) ,  Kim Won Seog (Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) ,  Katayama Naoyuki (Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan)
Material： Cancer Science (Web)  (Cancer Sci (Web))
Volume： 109  Issue： 6  Page： 2056-2062  Publication year： 2018 
JST Material Number： U0505A  ISSN： 1349-7006  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： *T cell lymphoma ,...
Semi thesaurus term： Chemoradiotherapy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1012430&from=J-GLOBAL&jstjournalNo=U0505A") }}

Author keywords (5)： concurrent chemoradiotherapy ,  early progression ,  Epstein-Barr virus ,  NK/T-cell lymphoma ,  soluble interleukin-2 receptor

JST classification (2)： Treatment for tumors in general  (GE03031L) ,  Tumors(=neoplasms)of ear,nose,pharynx and larynx  (GQ04000E)

Substance index (3)： Ifosfamide ,  Etoposide ,  Dexamethasone

Terms in the title (6)： 同時化学放射線療法 ,  治療 ,  T細胞リンパ腫 ,  患者 ,  早期 ,  疾患進行